Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

NCT01147666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease
Anemia

Interventions

DRUG: Roxadustat
DRUG: Epoetin Alfa
OTHER: Placebo

Sponsor

Kyntra Bio

Collaborators

[object Object]
[object Object]